Fundraising Fox

Sean P. Nolan

Chief Executive Officer and Board Chairman at Taysha Gene Therapies

Greater Chicago Area

About

Nolan previously led AveXis Inc. as President and CEO from 2015 to 2018, and held senior roles including Chief Business Officer at InterMune, Chief Commercial Officer at Reata Pharmaceuticals, and President of Lundbeck Inc., the company's US affiliate formerly known as Ovation Pharmaceuticals. His earlier work at Lundbeck spanned product development, global project management, and commercial integration following the Ovation acquisition.

Chief Executive Officer and Board Chairman at Taysha Gene Therapies

Intro paths

→

In turn, Sean can intro founders to Taysha Gene Therapies's investors below.

Taysha Gene Therapies's investors · 2

GV (Google Ventures)Mountain View · $250K – $50M checksPBM CapitalCharlottesville · since 2022

Co-founders at Taysha Gene Therapies

RS
R.A. Session IIExecutive Officer, Director

Experience

  1. Taysha Gene TherapiesChief Executive Officercurrent2022 — present
  2. Taysha Gene TherapiesChairman of the Board of Directorscurrent2020 — present
  3. AveXis Inc.President and Chief Executive Officer2015 — 2018Greater Chicago Area
  4. InterMuneChief Business Officer2013 — 2015
  5. Reata PharmaceuticalsChief Commercial Officer2011 — 2012
  6. LundbeckPresident of Lundbeck Inc. (US Affiliate of Lundbeck, Formerly Ovation Pharmaceuticals)2009 — 2010
  7. LundbeckChief Commercial Officer/Integration Leader2009
  8. LundbeckVP, Product Development and Global Project Management2008 — 2009
  9. LundbeckVP, CNS Business Unit2006 — 2008
  10. LundbeckVP, Marketing and Sales Operations2004 — 2005
  11. AbbottSenior Director, Sales Operations2003 — 2004
  12. AbbottDirector of Sales, Anti-Infectives2001 — 2003
  13. AbbottDirector of Sales, Neuroscience1999 — 2001
  14. AbbottRegional Manager, Long Term Care1999

Skills & more

Leadership27Strategy52Management6Biopharmaceuticals28Commercialization29Product Development9Neuroscience13FDA16Cardiology11Pharmaceutical Sales25Business Strategy7Marketing Strategy5
+12 moreMarket AccessNeurologySales OperationsBiotechnologyClinical TrialsLifesciencesMergers & AcquisitionsProduct LaunchIntegrationCross-functional Team LeadershipPharmaceuticsPharmaceutical Industry

From Sean's professional profile.

Frequently asked questions

Who is Sean P. Nolan?
Nolan previously led AveXis Inc. as President and CEO from 2015 to 2018, and held senior roles including Chief Business Officer at InterMune, Chief Commercial Officer at Reata Pharmaceuticals, and President of Lundbeck Inc., the company's US affiliate formerly known as Ovation Pharmaceuticals. His earlier work at Lundbeck spanned product development, global project management, and commercial integration following the Ovation acquisition.
Where does Sean P. Nolan work?
Sean P. Nolan is Chief Executive Officer and Board Chairman at Taysha Gene Therapies.
Where did Sean P. Nolan go to school?
Sean P. Nolan studied at John Carroll University (B.S., Biology).

Same school

Also attended John Carroll University10

Turner NasheInvestor at Side Door VenturesThomas FrazierProfessor of Psychology, John Carroll University at AIFErika CrandallChief Risk Officer at APXDaniel AnstandigOperating Advisor at Updata PartnersThomas WardInvestor at New York AngelsFrank KlemensManaging Director, Generation Food Rural Partners Fund at Big Idea Ventures

+ 4 more

Shared employers

Also worked at InterMune3

Jonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesPeter Van Vlasselaer, PhDVenture Partner at SR One Capital ManagementJen HerbachFounder at Adventris Pharmaceuticals

Also worked at Reata Pharmaceuticals5

Ashley SwerenOperations / Compliance at Standard CryptoJami TaylorHealthcare Operating Partner at RueOne InvestmentsJack NielsenManaging Partner at Vivo CapitalStephen CurtisManaging Partner at MPM BioImpactAnthony ArceciSenior Associate at RA Capital

Also worked at Lundbeck4

Christian Krog-JensenInvestor at Almi InvestEric FloydRegulatory Advisor at 2Flo VenturesErik SteffensenExpert advisor at VÅR VenturesJeff BerkowitzEquity Partner at Recode Ventures

Also worked at Abbott63

Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundClaire YoonAssociate at Scale Venture PartnersJim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalCharles BeyrouthyFounder & Managing Partner at Forma PrimeFederico RaneroVenture Partner at NazcaJennifer SmoterChief Communications & Governance Officer at Takeda Ventures

+ 57 more